Recordati Investor Relations Material
Latest events
Q4 2023
Recordati
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Recordati Industria Chimica e Farmaceutica S.p.A.
Access all reports
Recordati Industria Chimica e Farmaceutica S.p.A., engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. It operates through three segments: Ethical Division, Orphan Drugs Division, and Others. The Ethical Division offers a range of branded prescription products active in therapeutic areas comprising products for cardiovascular system disorders; respiratory system diseases; digestive and metabolism therapies; anti-infectives; hormones and synthetic substitutes; central nervous system disorders; and oncology drugs.The Orphan Drugs Division offers Cerliponase Alfa for treatment of neuronal ceroid lipofuscinoses type 2 (CLN2), a neurodegenerative disease; Laronidase for treatment of mucopolysaccharidosis I, an enzyme deficiency that causes progressive damage to various parts of body.
Key slides for Recordati Industria Chimica e Farmaceutica S.p.A.
Q4 2023
Recordati Industria Chimica e Farmaceutica S.p.A.
Q4 2023
Recordati Industria Chimica e Farmaceutica S.p.A.
Latest articles
Sundar Pichai: CEO of Alphabet and Google
Explore Sundar Pichai's improbable journey from Chennai, India, to becoming one of the most powerful individuals on the planet.
19 Apr 2024
The Three Cornerstones of Serial Acquirer Success
Explore what is behind successful serial acquirers: efficient capital use, decentralization, and a strong focus on people.
19 Apr 2024
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Ticker symbol
Country
🇮🇹 Italy